Research Archive — Page 13 of 139

Clostridium difficile bacterium, 3D illustration
January 28, 2026

Gut microbiome differs according to C. diff symptom status

In a study of children with symptomatic or asymptomatic C. diff, symptom status loomed as the strongest association with differences in gut microbial abundance and diversity.

By Paul Govern
A standard heart transplant requires surgical many types of instruments. (photo by Erin O. Smith)
January 21, 2026

New donor organ storage method helps reduce rates of severe primary graft dysfunction

Methods such as the cold storage system make it possible to preserve organs for longer after donation, expanding the pool of available organs.

By Matt Batcheldor
Close-up of a pregnant person in a light pink jacket and white top resting both hands on their belly.
January 21, 2026

Study details the downsides of testing for pregnancy too early

More than 40% of the women reported that they tested their urine for human chorionic gonadotropin, a hormone released by the placenta, four or more days before their expected periods.

By Bill Snyder
A child in a red hoodie wears an external cochlear implant processor behind the right ear while facing a large anatomical ear model in a clinical room.
January 21, 2026

New study finds that deaf children with cochlear implants read well, despite weak speech sound processing

Vanderbilt Health researchers report that many prelingually deaf children who use cochlear implants achieve age-typical language and reading comprehension.

By Danny Bonvissuto
(iStock)
January 20, 2026

VIGH, Ugandan partners land grant to study bunyaviruses in Tennessee and Uganda

Bunyaviruses can lead to many illnesses, ranging from mild fevers to serious and sometimes deadly diseases such as hemorrhagic fevers and encephalitis in both children and adults.

By Kristin Centers
(Adobe Stock)
January 16, 2026

Vanderbilt Health team finds potent antibody that neutralizes two dangerous viruses

The single administration of an antibody that provides cross-protection against both RSV and hMPV infection could provide logistical and economic advantages over the need to develop and administer multiple virus-specific monoclonal antibodies.

By Bill Snyder